ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549
______________________

 

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2017

 

Commission File Number: 001-36073

 

                    ENZYMOTEC LTD.                     
(Translation of registrant’s name into English)

 

Sagi 2000 Industrial Area
P.O. Box 6

 Migdal Ha’Emeq 2310001, Israel
 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F  ☒         Form 40-F   ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   ☐

 

CONTENTS

 

Acquisition of Product Portfolio

 

On August 30, 2017, Enzymotec Ltd. (“ Enzymotec ”) issued a press release announcing the acquisition of all rights pertaining to five nutritional products from Union Springs Healthcare, LLC, a company founded by renowned health care entrepreneur, Roger Griggs , who will now act as a senior advisor to Enzymotec.

 

A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K and is incorporated herein by reference.